Prescription drug · ANDA
Tridacaine XL (lidocaine) NDC 73352-845
Lidocaine 50 mg/g · Patch · Topical · Trifluent Pharma LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73352-845-30 | 73352084530 | 30 PACKET in 1 BOX (73352-845-30) / 1 g in 1 PACKET (73352-845-01)Marketed from Sep 20, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tridacaine XL
- Generic name (nonproprietary)
- lidocaine
- Active ingredients
- Lidocaine — 50 mg/g
- Dosage form
- Patch
- Route
- Topical
- Labeler
- Trifluent Pharma LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209190
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 73352-845_a94ac408-bd85-4a3e-90fb-123c3788a25fSPL ID a94ac408-bd85-4a3e-90fb-123c3788a25fSPL set ID 032b37a7-8a47-4809-a330-c76314225cbdRxCUI 1745091, 2678310UNII 98PI200987UPC 0373352845309
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473352084530followed by a unit qualifier and the quantityPackage 73352-0845-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATION AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209190
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | St. Mary's Medical Park Pharmacy | 60760-657 |
| Lidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | NuCare Pharmaceuticals,Inc. | 68071-3620 |
| Lidox 5 Patchlidocaine 5% patch | Lidocaine 50 mg/g | PatchTopical | Injecta Medcial LLC | 87234-0505 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | REMEDYREPACK INC. | 70518-4487 |
| Lidocaine 5% Patchlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | Medcore LLC | 82461-611 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | YARAL Pharma Inc. | 82347-0505 |
| Tridacaine IIIlidocaine | Lidocaine 50 mg/g | PatchTopical | Trifluent Pharma LLC | 73352-835 |
| Lidocanlidocaine 5% | Lidocaine 700 mg/1 | PatchTopical | PURETEK CORPORATION | 59088-905 |
| Lidocan VIIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-900 |
| Lidocan VIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-911 |
| Lidocan IIIlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-907 |
| Lidocan Vlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-909 |
| Lidocan IVlidocaine 5% | Lidocaine 50 mg/g | PatchTopical | PURETEK CORPORATION | 59088-910 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | A-S Medication Solutions | 50090-7857 |
| Lidocaine 5% | Lidocaine 50 mg/g | PatchTopical | Asclemed USA, Inc. | 76420-899 |